We examined the apoptosis-inducing potency of MHY2245, using the SKOV3 ovarian carcinoma cell line because this cell line demonstrates a substantial expression level of SIRT1, has mainly null-typep53 genes and this type of cancer is the most prevalent malignancy in women. This evidence concerns the gene SIRT1 and cancer.